Careers  |  Media  |  Contact us

Hereditary cancer gene panel_ONCO (106 genes)

Test Name

Hereditary cancer gene panel_ONCO (106 genes)

Home Collection, Lab Visit

Test Code

GEN0487_ONCO

Test Components/ Genes/ Parameters

AIP, ALK, APC, AR, ATM, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1B, CD82, CDC73, CDH1, CDK4, CDKN1C, CDKN2A, CEBPA, CEP57, CHEK2, CYLD, DDB2, DICER1, DIS3L2, EGFR, ELAC2, ENG, EPCAM, ERCC2, ERCC3, ERCC4, ERCC5, EXT1, EXT2, EZH2, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GATA2, GPC3, HRAS, KIT, MAX, MEN1, MET, MLH1, MLH3, MRE11A, MSH2, MSH3, MSH6, MSR1, MUTYH, MXI1, NBN, NF1, NF2, NSD1, PALB2, PHOX2B, PMS1, PMS2, PRF1, PRKAR1A, PTCH1, PTEN, RAD5, RAD51C, RAD51D, RB1, RECQL4, RET, RHBDF2, RNASEL, RUNX1, SBDS, SDHAF2, SDHB, SDHC, SDHD, SLX4, SMAD4, SMARCB1, STK11, SUFU, TGFBR2, TMEM127, TP53, TSC1, TSC2, VHL, WRN, WT1, XPA, XPC

Sample Report

Click on Icon

Test Information

TAT DETAILS

21 days

PRE-TEST INSTRUCTIONS

Whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated.

CLINICAL UTILITY

The test analyzes 106 genes associated with Hereditary Cancers. Assay detects Missense / Nonsense / Splice Site / Inframe Deletions / Frameshift / CNV Coverage at a read depth of 80-100x

SPECIMEN STABILITY

Transport at ambient (18-25°C) temperature

METHODOLOGY

NGS

STORAGE TEMPERATURE

NA

SPECIMEN TYPE

“Whole blood – EDTA vacutainer Dry – DBS card Amniotic Fluid – Sterile 15 ml Falcon tube Corionic Villus Sample – Sterile 15 ml Falcon tube with nutrient medium (provided by LifeCell) DNA – 1.5ml sterile cryotube”””

Frequently Asked Questions

Hereditary cancer gene panel_ONCO (106 genes)
The test analyzes 106 genes associated with Hereditary Cancers. Assay detects Missense / Nonsense / Splice Site / Inframe Deletions / Frameshift / CNV Coverage at a read depth of 80-100x
The healthy person has to give 10 ml blood/saliva which can be collected from patient’s home
The test is recommended when there is a family history of Hereditary Cancers
The test is performed with the Next generation sequencing technique
There is a 10ml blood draw so no risk associated
Result is reported as Pathogenic/No pathogenic or likely pathogenic variants causative of the reported phenotype were identified. Correlation with clinical profile and family history is required